mosquitos, matching the hospital-reported cases. This gave new insights for the researchers to create new and improved models that are more reliable and accurate for the complex dynamics of infectious disease. How does species adaptation occur at the genomic level?
Running Hot and Cold on the Trail to Measuring Adaptation in Fruit Flies
How does species adaptation occur at the genomic level? With the ability to rapidly sequence whole genomes at low cost, next-generation sequencing has ushered in a new era of excitement in experimental evolutionary biology. The ability to manipulate model organisms and sequence whole genomes to pinpoint which genes are responsible for adaptation within a given population-dubbed "evolve and resequence"-now aims to fill in the gaps. Tobler et al. (2013) used an experimental genetic workhorse, the fruit fly Drosophila melanogaster, and subjected a population to two different environments, one hot and one cold, and asked whether they could quantify the genetic response in each. Wild flies were collected and expanded to a population of 1,000, grown in the hot and cold environments for at least 15 generations, and then subjected to wholegenome sequencing.
Identifying a large number of variants involved in the adaptive response (called candidates), the authors provide convincing evidence that their candidates include loci with functions specific to either the hot or cold environment.
Nevertheless, they also deduced that the number of candidate loci was greatly overestimated due to a lack of independence among them that was previously unrecognized. The authors outline how this problem, which severely limits the ability to reliably fine-map such sites, could be ameliorated by modifications to the design of such studies.
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Staying a Step Ahead of Influenza
Every fall, the latest batch of flu vaccines attempts to keep society a step ahead of the evolution of flu virus. Heroic worldwide surveillance efforts have avoided a repeat of the 1918 flu pandemic, but as shown in the recent H1N1 outbreak, viruses can still outwit even the best public health efforts. During the H1N1 outbreak, antiviral drugs offered the only hope against emergent flu strains. Two drug classes: adamantanes (FDA approved in 1966) and neuraminidase inhibitors (oseltamivir, FDA approved in 1999) represent two classes of drugs that target a viral anion channel and cell surface antigen, respectively, thereby preventing or treating infection.
In an ambitious study, the authors attempt to trace drug resistance against all strains of the flu by using an extensive influenza virus database containing all known genetic sequence information (70,000 complete nucleotide sequences) for influenza strains. Using a phylogenetic approach, Garcia and Aris-Brosou (2013) examined the evolutionary history of antiviral drug resistance. "Although the approaches employed in our study are not novel in themselves, the scale of the analyses is unprecedented and allowed us to track in public databases the dynamics of all known mutations involved in drug resistance," reported Aris-Brosou.
